Search

Your search keyword '"De Michele, Lucrezia"' showing total 21 results
Start Over Author "De Michele, Lucrezia"
21 results on '"De Michele, Lucrezia"'

2. Significant burden of post-COVID exertional dyspnoea in a South-Italy region: knowledge of risk factors might prevent further critical overload on the healthcare system

Author

Resta, Emanuela, primary, Cuscianna, Eustachio, additional, Pierucci, Paola, additional, Custodero, Carlo, additional, Solfrizzi, Vincenzo, additional, Sabbà, Carlo, additional, Palmisano, Chiara Maria, additional, Barratta, Federica, additional, De Candia, Maria Luisa, additional, Tummolo, Maria Grazia, additional, Capozza, Elena, additional, Lomuscio, Sonia, additional, De Michele, Lucrezia, additional, Tafuri, Silvio, additional, Resta, Onofrio, additional, and Lenato, Gennaro Mariano, additional

Published
2023
Full Text
View/download PDF

4. Significant burden of post-COVID exertional dyspnoea in a South-Italy region: knowledge of risk factors might prevent further critical overload on the healthcare system.

Author

Resta, Emanuela, Cuscianna, Eustachio, Pierucci, Paola, Custodero, Carlo, Solfrizzi, Vincenzo, Sabbà, Carlo, Palmisano, Chiara Maria, Barratta, Federica, Luisa De Candia, Maria, Tummolo, Maria Grazia, Capozza, Elena, Lomuscio, Sonia, De Michele, Lucrezia, Tafuri, Silvio, Resta, Onofrio, and Lenato, Gennaro Mariano

Published
2024
Full Text
View/download PDF

5. Relevance of comorbidities on initial combination therapy in pulmonary arterial hypertension

Author

Badagliacca, Roberto, primary, D'Alto, Michele, additional, Ghio, Stefano, additional, Argiento, Paola, additional, Brunetti, Natale Daniele, additional, Casu, Gavino, additional, Cedrone, Nadia, additional, Confalonieri, Marco, additional, Corda, Marco, additional, Correale, Michele, additional, D'Agostino, Carlo, additional, De Michele, Lucrezia, additional, Di Marino, Serena, additional, Filomena, Domenico, additional, Galgano, Giuseppe, additional, Greco, Alessandra, additional, Lombardi, Carlo, additional, Manzi, Giovanna, additional, Mercurio, Valentina, additional, Mulè, Massimiliano, additional, Paciocco, Giuseppe, additional, Papa, Silvia, additional, Romeo, Emanuele, additional, Scelsi, Laura, additional, Stolfo, Davide, additional, Vitulo, Patrizio, additional, and Vizza, Carmine Dario, additional

Published
2022
Full Text
View/download PDF

6. The paradox of pulmonary arterial hypertension in Italy in the COVID-19 era: is risk of disease progression around the corner?

Author

Badagliacca, Roberto, primary, Papa, Silvia, additional, D'Alto, Michele, additional, Ghio, Stefano, additional, Agostoni, Piergiuseppe, additional, Ameri, Pietro, additional, Argiento, Paola, additional, Brunetti, Natale Daniele, additional, Casamassima, Vito, additional, Casu, Gavino, additional, Cedrone, Nadia, additional, Confalonieri, Marco, additional, Corda, Marco, additional, Correale, Michele, additional, D'Agostino, Carlo, additional, De Michele, Lucrezia, additional, Famoso, Giulia, additional, Galgano, Giuseppe, additional, Greco, Alessandra, additional, Lombardi, Carlo Mario, additional, Manzi, Giovanna, additional, Madonna, Rosalinda, additional, Mercurio, Valentina, additional, Mulè, Massimiliano, additional, Paciocco, Giuseppe, additional, Romaniello, Antonella, additional, Romeo, Emanuele, additional, Scelsi, Laura, additional, Serra, Walter, additional, Stolfo, Davide, additional, Toma, Matteo, additional, Vatrano, Marco, additional, Vitulo, Patrizio, additional, and Vizza, Carmine Dario, additional

Published
2022
Full Text
View/download PDF

8. Post severe COVID-19 infection lung damages study. The experience of early three months multidisciplinary follow-up

Author

De Michele, Lucrezia, primary, Pierucci, Paola, additional, Giovannetti, Guido, additional, De Ceglie, Michele, additional, Dimitri, Michela, additional, Mirabile, Alessandra, additional, Quaranta, Vitaliano, additional, Scardapane, Arnaldo, additional, D'Agostino, Carlo, additional, and Carpagnano, Giovanna Elisiana, additional

Published
2022
Full Text
View/download PDF

9. Inadvertent left ventricular placement of ICD lead through the left subclavian artery right positioned in a patient with situs viscerum inversus and Kartagener syndrome

Author

Carretta, Domenico, primary, Castellano, Maria, additional, Gianfrancesco, Domenico, additional, De Michele, Lucrezia, additional, Cozzolino, Monica, additional, Pedote, Pasquale, additional, Angiletta, Domenico, additional, Pulli, Raffaele, additional, Colonna, Paolo, additional, and D'Agostino, Carlo, additional

Published
2022
Full Text
View/download PDF

12. Risk Reduction and Hemodynamics with Initial Combination Therapy in Pulmonary Arterial Hypertension

Author

Badagliacca, Roberto, primary, D’Alto, Michele, additional, Ghio, Stefano, additional, Argiento, Paola, additional, Bellomo, Vincenzo, additional, Brunetti, Natale Daniele, additional, Casu, Gavino, additional, Confalonieri, Marco, additional, Corda, Marco, additional, Correale, Michele, additional, D’Agostino, Carlo, additional, De Michele, Lucrezia, additional, Galgano, Giuseppe, additional, Greco, Alessandra, additional, Lombardi, Carlo, additional, Manzi, Giovanna, additional, Mercurio, Valentina, additional, Mulè, Massimiliano, additional, Paciocco, Giuseppe, additional, Papa, Silvia, additional, Romeo, Emanuele, additional, Scelsi, Laura, additional, Stolfo, Davide, additional, Vitulo, Patrizio, additional, Naeije, Robert, additional, and Vizza, Carmine Dario, additional

Published
2021
Full Text
View/download PDF

15. Multifactorial Genesis of a Seeming Case of Pulmonary Hypertension.

Author

Musci, Rita Leonarda, De Michele, Lucrezia, D'Agostino, Carlo, and Colonna, Paolo

Abstract

Herein, we report the case of a 44-year-old female with end-stage renal disease on hemodialysis. She was admitted to our hospital to evaluate if she was eligible for a kidney transplant. Transthoracic echocardiography showed a markedly dilated coronary sinus and an unexpected finding of increased right ventriculoatrial gradient. A saline contrast echocardiography to confirm the presence of persistent left superior vena cava (PLSVC) was not performed because of arteriovenous fistula (FAV) for hemodialysis on the left forearm. Therefore, computed tomography angiography was performed, and it showed the PLSVC. We also proceeded with a transesophageal echocardiography which showed an atrial septal defect (ASD) of the sinus venous type hemodynamically significant. In this case, we identified a rare association of PLSVC with a ASD; therefore, there is a right ventricular volume overload because of the ASD hemodynamically significant and high flow FAV leading to a condition of a seeming pulmonary hypertension. [ABSTRACT FROM AUTHOR]

Published
2017
Full Text
View/download PDF

16. Relevance of comorbidities on initial combination therapy in pulmonary arterial hypertension

Author

Roberto Badagliacca, Michele D’Alto, Stefano Ghio, Paola Argiento, Natale Daniele Brunetti, Gavino Casu, Nadia Cedrone, Marco Confalonieri, Marco Corda, Michele Correale, Carlo D’Agostino, Lucrezia De Michele, Serena Di Marino, Domenico Filomena, Giuseppe Galgano, Alessandra Greco, Carlo Lombardi, Giovanna Manzi, Valentina Mercurio, Massimiliano Mulè, Giuseppe Paciocco, Silvia Papa, Emanuele Romeo, Laura Scelsi, Davide Stolfo, Patrizio Vitulo, Carmine Dario Vizza, and The Italian Pulmonary Hypertension NETwork, Confalonieri Paola, Salton Francesco, Albera Carlo., Badagliacca, Roberto, D'Alto, Michele, Ghio, Stefano, Argiento, Paola, Brunetti, Natale Daniele, Casu, Gavino, Cedrone, Nadia, Confalonieri, Marco, Corda, Marco, Correale, Michele, D'Agostino, Carlo, De Michele, Lucrezia, Di Marino, Serena, Filomena, Domenico, Galgano, Giuseppe, Greco, Alessandra, Lombardi, Carlo, Manzi, Giovanna, Mercurio, Valentina, Mulè, Massimiliano, Paciocco, Giuseppe, Papa, Silvia, Romeo, Emanuele, Scelsi, Laura, Stolfo, Davide, Vitulo, Patrizio, Vizza, Carmine Dario, Roberto, Badagliacca, Michele, D’Alto, Stefano, Ghio, Paola, Argiento, Natale Daniele Brunetti, Gavino, Casu, Nadia, Cedrone, Marco, Corda, Michele, Correale, Carlo, D’Agostino, Lucrezia De Michele, Serena Di Marino, Domenico, Filomena, Giuseppe, Galgano, Alessandra, Greco, Carlo, Lombardi, Giovanna, Manzi, Valentina, Mercurio, Massimiliano, Mulè, Giuseppe, Paciocco, Silvia, Papa, Emanuele, Romeo, Laura, Scelsi, Patrizio, Vitulo, Carmine Dario Vizza, and The Italian Pulmonary Hypertension NETwork, Confalonieri, Paola, Salton, Francesco, and Albera, Carlo.

Subjects
Pulmonary and Respiratory Medicine, cardiovascular risk factors, co-morbidities, co-morbiditie, pulmonary arterial hypertension (PAH), pulmonary vascular resistance (PVR), oral combination therapy, cardiovascular comorbidities, pulmonary arterial hypertension, combination therapy
Abstract

RationaleDemographic characteristics of pulmonary arterial hypertension (PAH) patients have changed over time, but the effects of cardiovascular risk factors on risk status and pulmonary vascular resistance (PVR) reduction with initial oral combination therapy are not known. Therefore, we tested the relevance of cardiovascular comorbidities in this setting.MethodsThe study enrolled 181 treatment-naive PAH patients with a 6-month (IQR 144–363 days) right heart catheterisation and risk assessment after initial oral combination therapy.ResultsGroup A included 96 (53.0%) patients without cardiac comorbidities; Group B included 54 (29.8%) patients with one cardiac comorbidity; Group C included 31 (17.1%) patients with two cardiac comorbidities or more. Group C patients were older with a balanced sex distribution. There was a significant difference in PVR reduction moving from the absence to one or at least two cardiac comorbidities, respectively: median −45.0%, −30.3%, −24.3%. A European Respiratory Society/European Society of Cardiology low-risk status was present at first follow-up in 50 (52.0%) patients in Group A, 19 (35.1%) in Group B and 9 (29.0%) in Group C; a REVEAL 2.0 low-risk status was present at first follow-up in 41 (42.0%) patients in Group A, 15 (27.7%) in Group B and 7 (22.6%) in Group C. Group A patients were 2.3 times more likely to achieve/maintain a low-risk status compared with Group B and C (OR 2.27, 95% CI 1.15–4.54, p=0.02). No significant difference was observed between patients with non-cardiac comorbidities and those without comorbidities.ConclusionInitial oral combination therapy seems associated with a less effective response for patients with cardiovascular comorbidities compared with the others, related to the magnitude of treatment-induced decrease in PVR.

Published
2022

17. Risk Reduction and Hemodynamics with Initial Combination Therapy in Pulmonary Arterial Hypertension

Author

Davide Stolfo, Michele Correale, Paola Argiento, Marco Confalonieri, Alessandra Greco, Michele D'Alto, Roberto Badagliacca, Laura Scelsi, Gavino Casu, Carmine Dario Vizza, Carlo D'Agostino, Stefano Ghio, Giuseppe Paciocco, Emanuele Romeo, Lucrezia De Michele, Natale Daniele Brunetti, Marco Corda, Silvia Papa, Robert Naeije, Valentina Mercurio, Massimiliano Mulè, Giovanna Manzi, Carlo Lombardi, Giuseppe Galgano, Patrizio Vitulo, Vincenzo Bellomo, Badagliacca, Roberto, D’Alto, Michele, Ghio, Stefano, Argiento, Paola, Bellomo, Vincenzo, Daniele Brunetti, Natale, Casu, Gavino, Confalonieri, Marco, Corda, Marco, Correale, Michele, D’Agostino, Carlo, De Michele, Lucrezia, Galgano, Giuseppe, Greco, Alessandra, Lombardi, Carlo, Manzi, Giovanna, Mercurio, Valentina, Mulè, Massimiliano, Paciocco, Giuseppe, Papa, Silvia, Romeo, Emanuele, Scelsi, Laura, Stolfo, Davide, Vitulo, Patrizio, Naeije, Robert, Dario Vizza, Carmine, D'Alto, Michele, Brunetti, Natale Daniele, D'Agostino, Carlo, Mulé, Massimiliano, and Vizza, Carmine Dario

Subjects
Pulmonary and Respiratory Medicine, medicine.medical_specialty, Combination therapy, pulmonary arterial hypertension, right heart remodeling, echocardiography, pulmonary vascular resistance, upfront therapy, Haemodynamic response, Cardiac index, Hemodynamics, Critical Care and Intensive Care Medicine, 03 medical and health sciences, 0302 clinical medicine, Interquartile range, Internal medicine, medicine.artery, Medicine, 030212 general & internal medicine, business.industry, Endothelin receptor antagonist, medicine.anatomical_structure, 030228 respiratory system, Pulmonary artery, Vascular resistance, Cardiology, business
Abstract

Rationale: An initial oral combination of drugs is being recommended in pulmonary arterial hypertension (PAH), but the effects of this approach on risk reduction and pulmonary vascular resistance (PVR) are not known.Objectives: To test the hypothesis that a low-risk status would be determined by the reduction of PVR in patients with PAH treated upfront with a combination of oral drugs.Methods: The study enrolled 181 treatment-naive patients with PAH (81% idiopathic) with a follow-up right heart catheterization at 6 months (interquartile range, 144-363 d) after the initial combination of endothelin receptor antagonist + phosphodiesterase-5 inhibitor drugs and clinical evaluation and risk assessments by European guidelines and Registry to Evaluate Early and Long-Term PAH Disease Management scores.Measurements and Main Results: Initial combination therapy improved functional class and 6-minute-walk distance and decreased PVR by an average of 35% (median, 40%). One-third of the patients had a decrease in PVR

Published
2021

18. The paradox of pulmonary arterial hypertension in Italy in the COVID-19 era: is risk of disease progression around the corner?

Author

Roberto Badagliacca, Silvia Papa, Michele D'Alto, Stefano Ghio, Piergiuseppe Agostoni, Pietro Ameri, Paola Argiento, Natale Daniele Brunetti, Vito Casamassima, Gavino Casu, Nadia Cedrone, Marco Confalonieri, Marco Corda, Michele Correale, Carlo D'Agostino, Lucrezia De Michele, Giulia Famoso, Giuseppe Galgano, Alessandra Greco, Carlo Mario Lombardi, Giovanna Manzi, Rosalinda Madonna, Valentina Mercurio, Massimiliano Mulè, Giuseppe Paciocco, Antonella Romaniello, Emanuele Romeo, Laura Scelsi, Walter Serra, Davide Stolfo, Matteo Toma, Marco Vatrano, Patrizio Vitulo, Carmine Dario Vizza, Pietro Geri, Paola Confalonieri, Badagliacca, Roberto, Papa, Silvia, D'Alto, Michele, Ghio, Stefano, Agostoni, Piergiuseppe, Ameri, Pietro, Argiento, Paola, Daniele Brunetti, Natale, Casamassima, Vito, Casu, Gavino, Cedrone, Nadia, Confalonieri, Marco, Corda, Marco, Correale, Michele, D'Agostino, Carlo, De Michele, Lucrezia, Famoso, Giulia, Galgano, Giuseppe, Greco, Alessandra, Mario Lombardi, Carlo, Manzi, Giovanna, Madonna, Rosalinda, Mercurio, Valentina, Mulè, Massimiliano, Paciocco, Giuseppe, Romaniello, Antonella, Romeo, Emanuele, Scelsi, Laura, Serra, Walter, Stolfo, Davide, Toma, Matteo, Vatrano, Marco, Vitulo, Patrizio, Dario Vizza, Carmine, Geri, Pietro, and Confalonieri, Paola

Subjects
Pulmonary and Respiratory Medicine, Pulmonary Arterial Hypertension, SARS-CoV-2, COVID-19, Settore MED/11 - Malattie dell'Apparato Cardiovascolare, mortality, infection, pulmonary arterial hypertension, hospitalization, Natriuretic Peptide, Brain, Disease Progression, Humans, Familial Primary Pulmonary Hypertension, COVID-19, SARS-CoV-2
Abstract

ObjectiveThe coronavirus disease 2019 (COVID-19) outbreak has led to significant restrictions on routine medical care. We conducted a multicentre nationwide survey of patients with pulmonary arterial hypertension (PAH) to determine the consequences of governance measures on PAH management and risk of poor outcome in patients with COVID-19.Materials and methodsThe present study, which included 25 Italian centres, considered demographic data, the number of in-person visits, 6-min walk and echocardiographic test results, brain natriuretic peptide/N-terminal pro-brain natriuretic peptide test results, World Health Organization functional class assessment, presence of elective and non-elective hospitalisation, need for treatment escalation/initiation, newly diagnosed PAH, incidence of COVID-19 and mortality rates. Data were collected, double-checked and tracked by institutional records between March 1 and May 1, 2020, to coincide with the first peak of COVID-19 and compared with the same time period in 2019.ResultsAmong 1922 PAH patients, the incidences of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and COVID-19 were 1.0% and 0.46%, respectively, with the latter comparable to that in the overall Italian population (0.34%) but associated with 100% mortality. Less systematic activities were converted into more effective remote interfacing between clinicians and PAH patients, resulting in lower rates of hospitalisation (1.2% versus 1.9%) and related death (0.3% versus 0.5%) compared with 2019 (pConclusionA cohesive partnership between healthcare providers and regional public health officials is needed to prioritise PAH patients for remote monitoring by dedicated tools.

Published
2022

19. Inadvertent left ventricular placement of ICD lead through the left subclavian artery right positioned in a patient with situs viscerum inversus and Kartagener syndrome.

Author

Carretta D, Castellano M, Gianfrancesco D, De Michele L, Cozzolino M, Pedote P, Angiletta D, Pulli R, Colonna P, and D'Agostino C

Abstract

Inadvertent placement of pacemaker and implantable cardioverter-defibrillator (ICD) leads in the left ventricle is a rare but well-recognized complication of device implantation. We report a case of an unicameral ICD lead inadvertently placed through the left subclavian artery right positioned, across the aortic valve into the left ventricle, in a patient with situs viscerum inversus. A transthoracic echocardiogram about a month after the procedure showed an unusual course of the lead. The lead was successfully removed without complications or sequelae. < Learning objective: Subclavian artery accidental puncture during pacemaker / implantable cardioverter-defibrillator implantation is an important complication. With grown up congenital heart this complication could occur more frequently and with more serious complications if the patient's anatomy is not well framed and deepened by specific instrumental examinations. If the above complication is managed quickly and competently and if the artery is not instrumented, it does not cause serious consequences.>., (© 2021 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.)

Published
2021
Full Text
View/download PDF

20. [Diagnostic and therapeutic models for the management of acute pulmonary embolism: an issue of local available resources].

Author

Roncon L, Picariello C, Vatrano M, Enea I, Caravita S, De Michele L, Vanni S, Casazza F, Zonzin P, Bongarzoni A, D'Agostino C, Azzarito M, Urbinati S, Gulizia MM, and Gabrielli D

Subjects
Acute Disease, Anticoagulants therapeutic use, Cardiologists supply & distribution, Coronary Care Units supply & distribution, Europe, Hemodynamic Monitoring, Humans, Patient Care Team, Prognosis, Pulmonary Embolism complications, Risk Assessment, Symptom Assessment, Thrombolytic Therapy methods, Health Resources supply & distribution, Practice Guidelines as Topic, Pulmonary Embolism diagnosis, Pulmonary Embolism therapy
Abstract

Acute pulmonary embolism (PE) still represents the third leading cause of cardiovascular mortality in developed countries. In this regard, the last European guidelines offer important suggestions on the management of the disease in daily clinical practice but, at the same time, they do not take into account the feasibility of the recommendations according to the local available resources, including the presence or lack of adequate healthcare facilities (cardiological intensive care unit, cath-lab) or specialists (cardiologist available on a 24 h basis, interventional cardiologist, cardiac surgeon, etc.) all over the day. In the real clinical practice, those recommendations should be adapted to the local available resources. The aim of this document is to provide some suggestions regarding the diagnosis and treatment of acute PE, according to the possible available resources in different local circumstances.

Published
2020
Full Text
View/download PDF

21. [ANMCO statement: Arterial and venous thromboembolism: what implications for clinical practice?]

Author

Abrignani MG, Enea I, Colivicchi F, Roncon L, Aiello A, Becattini C, Bongarzoni A, Caravita S, Dasseni N, De Michele L, Faggiano PM, Mureddu GF, Picariello C, Rao CM, Riccio C, Urbinati S, Vanni S, Vatrano M, Di Lenarda A, Gabrielli D, and Gulizia MM

Subjects
Cardiovascular Diseases prevention & control, Humans, Primary Prevention methods, Risk Factors, Secondary Prevention methods, Thromboembolism prevention & control, Thromboembolism therapy, Venous Thromboembolism prevention & control, Venous Thromboembolism therapy, Cardiovascular Diseases etiology, Thromboembolism complications, Venous Thromboembolism complications
Abstract

Acute myocardial infarction, stroke, peripheral arterial disease and pulmonary embolism share thrombosis as a common mechanism. Some well-known risk factors for arterial thromboembolism are recognized as "weak risk factors" of venous one, too. Arterial and venous thrombosis share also some pathophysiological mechanisms, including inflammation, endothelial damage, and hypercoagulability. It is likely, thus, that any disease related to arterial and venous thrombosis belong to the same "pan-vascular syndrome", that constitutes itself a chronic, recurrent inflammatory disease. According to the available data, there are elements for implementing an omni-comprehensive cardiovascular evaluation after an episode of venous thromboembolism, requiring the investigations, in addition to the known unrecognized prothrombotic conditions, also of indirect signs and risk factors for a possible arterial thromboembolic event. Large, prospective studies are needed to establish the more appropriate therapeutic strategies in this context.The aim of the present statement is to make aware all the physicians involved in the management of arterial and venous diseases and to provide some tools for evaluating the implications of related major risk factors. Thus, it could be possible to lay the foundation for a reduction of total cardiovascular risk, in terms of primary and secondary prevention of arterial and venous thromboembolism.

Published
2019
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results